Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067378
  • December 2021
  • Healthcare
  • 254 Pages
Report Description

This report is a comprehensive study that examines the Digital Therapeutics industry in depth. With reference to key regions and major nations, the study specifies the product type of Digital Therapeutics as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Digital Therapeutics market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Digital Therapeutics market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Digital Therapeutics market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Digital Therapeutics Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Digital Therapeutics market study. The market dynamics and factors such as the threat of a Digital Therapeutics substitute, the threat of new entrants into the Digital Therapeutics market, buyer bargaining power, supplier bargaining power to Digital Therapeutics providing companies, and internal rivalry among Digital Therapeutics providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Digital Therapeutics market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Digital Therapeutics industry.
 
Digital Therapeutics Market Key Trends Analysis

The important factors influencing the growth of the Digital Therapeutics market have been examined in this report. The driving factors that are boosting demand for Digital Therapeuticss and the restraining factors that are slowing growth of the Digital Therapeutics industry are addressed in depth, as well as their implications for the worldwide Digital Therapeutics market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Digital Therapeutics Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Digital Therapeutics industry. On the basis of current and future trends, all segments of the Digital Therapeutics industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Digital Therapeutics Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Digital Therapeutics market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Digital Therapeutics market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Digital Therapeutics market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Digital Therapeutics market. All important stakeholders in the Digital Therapeutics value chain and technological ecosystem are expected to benefit from the insights offered in the Digital Therapeutics market research study.

In order to provide a broader understanding of the top competitors in the Digital Therapeutics market, the research includes a company market share analysis. 2morrow Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, BigHealth, Canary Health Inc., Click Therapeutics, Cognoa, Ginger.IoInc., Happify, Kaia Health, Lark Technologies, Livongo Health Inc., Mango Health Inc., Mindstrong Health, Noom Inc., Omada Health Inc., One Drop, Pear Therapeutics, Propeller Health, Proteus Digital Health Inc., Twine health Inc., Vitra Health, Welldoc Inc., Wellthy Therapeutics are among the major participants in the global Digital Therapeutics industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered 2morrow Inc., Akili Interactive Labs, Ayogo Health Inc., Better Therapeutics, BigHealth, Canary Health Inc., Click Therapeutics, Cognoa, Ginger.IoInc., Happify, Kaia Health, Lark Technologies, Livongo Health Inc., Mango Health Inc., Mindstrong Health, Noom Inc., Omada Health Inc., One Drop, Pear Therapeutics, Propeller Health, Proteus Digital Health Inc., Twine health Inc., Vitra Health, Welldoc Inc., Wellthy Therapeutics
 
Major Highlights of the Digital Therapeutics Market report study:
  • An in-depth examination of the global Digital Therapeutics industry will be published soon.
  • The study examines the global Digital Therapeutics market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Digital Therapeutics industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Digital Therapeutics market is being shaped by several major trends.
  • The size of the Digital Therapeutics market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Digital Therapeutics market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Digital Therapeutics market as follows:
Global Digital Therapeutics Market: By Product Type

  • Cardiovascular Disease
  • Central Nervous System Disorder
  • Chronic Respiratory Disease
  • Diabetes

Global Digital Therapeutics Market: By Application
  • Devices
  • Software.

Global Digital Therapeutics Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Digital Therapeutics market.
  • Universities and students
  • Other companies in the Digital Therapeutics market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Digital Therapeutics market

Manufacturers and Segments

  • 2morrow Inc.
  • Akili Interactive Labs
  • Ayogo Health Inc.
  • Better Therapeutics
  • BigHealth
  • Canary Health Inc.
  • Click Therapeutics
  • Cognoa
  • Ginger.IoInc.
  • Happify
  • Kaia Health
  • Lark Technologies
  • Livongo Health Inc.
  • Mango Health Inc.
  • Mindstrong Health
  • Noom Inc.
  • Omada Health Inc.
  • One Drop
  • Pear Therapeutics
  • Propeller Health
  • Proteus Digital Health Inc.
  • Twine health Inc.
  • Vitra Health
  • Welldoc Inc.
  • Wellthy Therapeutics
  • Cardiovascular Disease
  • Central Nervous System Disorder
  • Chronic Respiratory Disease
  • Diabetes
  • Devices
  • Software.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Digital Therapeutics Market Snapshot
          2.1.1. Global Digital Therapeutics Market By Cardiovascular Disease,2019
               2.1.1.1.
               2.1.1.2.Cardiovascular Disease
               2.1.1.3.Central Nervous System Disorder
               2.1.1.4.Chronic Respiratory Disease
          2.1.2. Global Digital Therapeutics Market By Devices,2019
               2.1.2.1.
               2.1.2.2.Devices
          2.1.3. Global Digital Therapeutics Market By End-use,2019
          2.1.4. Global Digital Therapeutics Market By Geography,2019

3. Global Digital Therapeutics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Digital Therapeutics Market Size (US$), By Cardiovascular Disease, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Cardiovascular Disease, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Cardiovascular Disease, 2020
     4.2. Global Digital Therapeutics Market Size (US$), By Cardiovascular Disease, 2018 – 2028

5. Global Digital Therapeutics Market Size (US$), By Devices, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Devices, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Devices, 2020
     5.2. Global Digital Therapeutics Market Size (US$), By Devices, 2018 – 2028

6. Global Digital Therapeutics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Digital Therapeutics Market Size (US$), By End-use, 2018 – 2028

7. Global Digital Therapeutics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Digital Therapeutics Market Analysis, 2018 – 2028 
          7.2.1. North America Digital Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Digital Therapeutics Market Size (US$), By Cardiovascular Disease, 2018 – 2028
          7.2.3. North America Digital Therapeutics Market Size (US$), By Devices, 2018 – 2028
          7.2.4. North America Digital Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Digital Therapeutics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Digital Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Digital Therapeutics Market Size (US$), By Cardiovascular Disease, 2018 – 2028
          7.3.3. Europe Digital Therapeutics Market Size (US$), By Devices, 2018 – 2028
          7.3.4. Europe Digital Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Digital Therapeutics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Digital Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Digital Therapeutics Market Size (US$), By Cardiovascular Disease, 2018 – 2028
          7.4.3. Asia Pacific Digital Therapeutics Market Size (US$), By Devices, 2018 – 2028
          7.4.4. Asia Pacific Digital Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Digital Therapeutics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Digital Therapeutics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Digital Therapeutics Market Size (US$), By Cardiovascular Disease, 2018 – 2028
          7.5.3. Latin America Digital Therapeutics Market Size (US$), By Devices, 2018 – 2028
          7.5.4. Latin America Digital Therapeutics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Digital Therapeutics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Digital Therapeutics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Digital Therapeutics Market Size (US$), By Cardiovascular Disease, 2018 – 2028
          7.6.3. MEA Digital Therapeutics Market Size (US$), By Devices, 2018 – 2028
          7.6.4. MEA Digital Therapeutics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Digital Therapeutics Providers
        8.4.1 2morrow Inc.
                8.4.1.1 Business Description
                8.4.1.2 2morrow Inc. Geographic Operations
                8.4.1.3 2morrow Inc. Financial Information
                8.4.1.4 2morrow Inc. Product Positions/Portfolio
                8.4.1.5 2morrow Inc. Key Developments
        8.4.2 Akili Interactive Labs
                8.4.2.1 Business Description
                8.4.2.2 Akili Interactive Labs Geographic Operations
                8.4.2.3 Akili Interactive Labs Financial Information
                8.4.2.4 Akili Interactive Labs Product Positions/Portfolio
                8.4.2.5 Akili Interactive Labs Key Developments
        8.4.3 Ayogo Health Inc.
                8.4.3.1 Business Description
                8.4.3.2 Ayogo Health Inc. Geographic Operations
                8.4.3.3 Ayogo Health Inc. Financial Information
                8.4.3.4 Ayogo Health Inc. Product Positions/Portfolio
                8.4.3.5 Ayogo Health Inc. Key Developments
        8.4.4 Better Therapeutics
                8.4.4.1 Business Description
                8.4.4.2 Better Therapeutics Geographic Operations
                8.4.4.3 Better Therapeutics Financial Information
                8.4.4.4 Better Therapeutics Product Positions/Portfolio
                8.4.4.5 Better Therapeutics Key Developments
        8.4.5 BigHealth
                8.4.5.1 Business Description
                8.4.5.2 BigHealth Geographic Operations
                8.4.5.3 BigHealth Financial Information
                8.4.5.4 BigHealth Product Positions/Portfolio
                8.4.5.5 BigHealth Key Developments
        8.4.6 Canary Health Inc.
                8.4.6.1 Business Description
                8.4.6.2 Canary Health Inc. Geographic Operations
                8.4.6.3 Canary Health Inc. Financial Information
                8.4.6.4 Canary Health Inc. Product Positions/Portfolio
                8.4.6.5 Canary Health Inc. Key Developments
        8.4.7 Click Therapeutics
                8.4.7.1 Business Description
                8.4.7.2 Click Therapeutics Geographic Operations
                8.4.7.3 Click Therapeutics Financial Information
                8.4.7.4 Click Therapeutics Product Positions/Portfolio
                8.4.7.5 Click Therapeutics Key Developments
        8.4.8 Cognoa
                8.4.8.1 Business Description
                8.4.8.2 Cognoa Geographic Operations
                8.4.8.3 Cognoa Financial Information
                8.4.8.4 Cognoa Product Positions/Portfolio
                8.4.8.5 Cognoa Key Developments
        8.4.9 Ginger.IoInc.
                8.4.9.1 Business Description
                8.4.9.2 Ginger.IoInc. Geographic Operations
                8.4.9.3 Ginger.IoInc. Financial Information
                8.4.9.4 Ginger.IoInc. Product Positions/Portfolio
                8.4.9.5 Ginger.IoInc. Key Developments
        8.4.10 Happify
                8.4.10.1 Business Description
                8.4.10.2 Happify Geographic Operations
                8.4.10.3 Happify Financial Information
                8.4.10.4 Happify Product Positions/Portfolio
                8.4.10.5 Happify Key Developments
        8.4.11 Kaia Health
                8.4.11.1 Business Description
                8.4.11.2 Kaia Health Geographic Operations
                8.4.11.3 Kaia Health Financial Information
                8.4.11.4 Kaia Health Product Positions/Portfolio
                8.4.11.5 Kaia Health Key Developments
        8.4.12 Lark Technologies
                8.4.12.1 Business Description
                8.4.12.2 Lark Technologies Geographic Operations
                8.4.12.3 Lark Technologies Financial Information
                8.4.12.4 Lark Technologies Product Positions/Portfolio
                8.4.12.5 Lark Technologies Key Developments
        8.4.13 Livongo Health Inc.
                8.4.13.1 Business Description
                8.4.13.2 Livongo Health Inc. Geographic Operations
                8.4.13.3 Livongo Health Inc. Financial Information
                8.4.13.4 Livongo Health Inc. Product Positions/Portfolio
                8.4.13.5 Livongo Health Inc. Key Developments
        8.4.14 Mango Health Inc.
                8.4.14.1 Business Description
                8.4.14.2 Mango Health Inc. Geographic Operations
                8.4.14.3 Mango Health Inc. Financial Information
                8.4.14.4 Mango Health Inc. Product Positions/Portfolio
                8.4.14.5 Mango Health Inc. Key Developments
        8.4.15 Mindstrong Health
                8.4.15.1 Business Description
                8.4.15.2 Mindstrong Health Geographic Operations
                8.4.15.3 Mindstrong Health Financial Information
                8.4.15.4 Mindstrong Health Product Positions/Portfolio
                8.4.15.5 Mindstrong Health Key Developments
        8.4.16 Noom Inc.
                8.4.16.1 Business Description
                8.4.16.2 Noom Inc. Geographic Operations
                8.4.16.3 Noom Inc. Financial Information
                8.4.16.4 Noom Inc. Product Positions/Portfolio
                8.4.16.5 Noom Inc. Key Developments
        8.4.17 Omada Health Inc.
                8.4.17.1 Business Description
                8.4.17.2 Omada Health Inc. Geographic Operations
                8.4.17.3 Omada Health Inc. Financial Information
                8.4.17.4 Omada Health Inc. Product Positions/Portfolio
                8.4.17.5 Omada Health Inc. Key Developments
        8.4.18 One Drop
                8.4.18.1 Business Description
                8.4.18.2 One Drop Geographic Operations
                8.4.18.3 One Drop Financial Information
                8.4.18.4 One Drop Product Positions/Portfolio
                8.4.18.5 One Drop Key Developments
        8.4.19 Pear Therapeutics
                8.4.19.1 Business Description
                8.4.19.2 Pear Therapeutics Geographic Operations
                8.4.19.3 Pear Therapeutics Financial Information
                8.4.19.4 Pear Therapeutics Product Positions/Portfolio
                8.4.19.5 Pear Therapeutics Key Developments
        8.4.20 Propeller Health
                8.4.20.1 Business Description
                8.4.20.2 Propeller Health Geographic Operations
                8.4.20.3 Propeller Health Financial Information
                8.4.20.4 Propeller Health Product Positions/Portfolio
                8.4.20.5 Propeller Health Key Developments
        8.4.21 Proteus Digital Health Inc.
                8.4.21.1 Business Description
                8.4.21.2 Proteus Digital Health Inc. Geographic Operations
                8.4.21.3 Proteus Digital Health Inc. Financial Information
                8.4.21.4 Proteus Digital Health Inc. Product Positions/Portfolio
                8.4.21.5 Proteus Digital Health Inc. Key Developments
        8.4.22 Twine health Inc.
                8.4.22.1 Business Description
                8.4.22.2 Twine health Inc. Geographic Operations
                8.4.22.3 Twine health Inc. Financial Information
                8.4.22.4 Twine health Inc. Product Positions/Portfolio
                8.4.22.5 Twine health Inc. Key Developments
        8.4.23 Vitra Health
                8.4.23.1 Business Description
                8.4.23.2 Vitra Health Geographic Operations
                8.4.23.3 Vitra Health Financial Information
                8.4.23.4 Vitra Health Product Positions/Portfolio
                8.4.23.5 Vitra Health Key Developments
        8.4.24 Welldoc Inc.
                8.4.24.1 Business Description
                8.4.24.2 Welldoc Inc. Geographic Operations
                8.4.24.3 Welldoc Inc. Financial Information
                8.4.24.4 Welldoc Inc. Product Positions/Portfolio
                8.4.24.5 Welldoc Inc. Key Developments
        8.4.25 Wellthy Therapeutics
                8.4.25.1 Business Description
                8.4.25.2 Wellthy Therapeutics Geographic Operations
                8.4.25.3 Wellthy Therapeutics Financial Information
                8.4.25.4 Wellthy Therapeutics Product Positions/Portfolio
                8.4.25.5 Wellthy Therapeutics Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Digital Therapeutics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Digital Therapeutics Market Revenue, By Cardiovascular Disease, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Digital Therapeutics Market Revenue, By Devices, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Digital Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Digital Therapeutics Market Revenue, By Cardiovascular Disease, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Digital Therapeutics Market Revenue, By Devices, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Digital Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Digital Therapeutics Market Revenue, By Cardiovascular Disease, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Digital Therapeutics Market Revenue, By Devices, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Digital Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Digital Therapeutics Market Revenue, By Cardiovascular Disease, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Digital Therapeutics Market Revenue, By Devices, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Digital Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Digital Therapeutics Market Revenue, By Cardiovascular Disease, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Digital Therapeutics Market Revenue, By Devices, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Digital Therapeutics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Digital Therapeutics: Market Segmentation 
FIG. 2 Global Digital Therapeutics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Digital Therapeutics Market, By Cardiovascular Disease, 2019 (US$ Mn) 
FIG. 5 Global Digital Therapeutics Market, By Devices, 2019 (US$ Mn) 
FIG. 6 Global Digital Therapeutics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Digital Therapeutics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Digital Therapeutics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Digital Therapeutics Providers, 2019
FIG. 11 Global Digital Therapeutics Market Revenue Contribution, By Cardiovascular Disease, 2019 & 2028 (Value %) 
FIG. 12 Global Digital Therapeutics Market Revenue Contribution, By Devices, 2019 & 2028 (Value %) 
FIG. 13 Global Digital Therapeutics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Digital Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Digital Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Digital Therapeutics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Digital Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Digital Therapeutics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Digital Therapeutics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Digital Therapeutics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Digital Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  North America Digital Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  North America Digital Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Europe Digital Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Digital Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Digital Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Digital Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Digital Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Digital Therapeutics Market Value, By Country, 2018 – 2028
TABLE  Latin America Digital Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Digital Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Digital Therapeutics Market Value, By Country, 2018 – 2028
TABLE  MEA Digital Therapeutics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Digital Therapeutics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Digital Therapeutics Market Value, By Country, 2018 – 2028
TABLE  2morrow Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Akili Interactive Labs: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ayogo Health Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Better Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BigHealth: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Canary Health Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Click Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cognoa: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ginger.IoInc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Happify: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Kaia Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lark Technologies: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Livongo Health Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mango Health Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Mindstrong Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Noom Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Omada Health Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  One Drop: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Pear Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Propeller Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Proteus Digital Health Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Twine health Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Vitra Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Welldoc Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Wellthy Therapeutics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Digital Therapeutics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Digital Therapeutics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Digital Therapeutics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Digital Therapeutics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Digital Therapeutics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Digital Therapeutics Providers, 2016
FIG.  Global Digital Therapeutics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Cardiovascular Disease Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Central Nervous System Disorder Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Chronic Respiratory Disease Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Diabetes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Digital Therapeutics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Devices Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Software. Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Digital Therapeutics Market Value, 2018 – 2028, (US$ Mn)